Your browser doesn't support javascript.
loading
Novel combined Ato-C treatment synergistically suppresses proliferation of Bcr-Abl-positive leukemic cells in vitro and in vivo.
Wahiduzzaman, Md; Ota, Akinobu; Karnan, Sivasundaram; Hanamura, Ichiro; Mizuno, Shohei; Kanasugi, Jo; Rahman, Md Lutfur; Hyodo, Toshinori; Konishi, Hiroyuki; Tsuzuki, Shinobu; Takami, Akiyoshi; Hosokawa, Yoshitaka.
Affiliation
  • Wahiduzzaman M; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, 480-1195, Japan.
  • Ota A; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, 480-1195, Japan. Electronic address: aota@aichi-med-u.ac.jp.
  • Karnan S; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, 480-1195, Japan.
  • Hanamura I; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan.
  • Mizuno S; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan.
  • Kanasugi J; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan.
  • Rahman ML; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, 480-1195, Japan.
  • Hyodo T; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, 480-1195, Japan.
  • Konishi H; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, 480-1195, Japan.
  • Tsuzuki S; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, 480-1195, Japan.
  • Takami A; Division of Hematology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan.
  • Hosokawa Y; Department of Biochemistry, Aichi Medical University School of Medicine, Nagakute, Aichi, 480-1195, Japan.
Cancer Lett ; 433: 117-130, 2018 10 01.
Article de En | MEDLINE | ID: mdl-29944906

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie myéloïde chronique BCR-ABL positive / Cisplatine / Résistance aux médicaments antinéoplasiques / Trioxyde d'arsenic / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Cancer Lett Année: 2018 Type de document: Article Pays d'affiliation: Japon Pays de publication: Irlande

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie myéloïde chronique BCR-ABL positive / Cisplatine / Résistance aux médicaments antinéoplasiques / Trioxyde d'arsenic / Antinéoplasiques Type d'étude: Prognostic_studies Limites: Animals / Humans Langue: En Journal: Cancer Lett Année: 2018 Type de document: Article Pays d'affiliation: Japon Pays de publication: Irlande